Tonix Pharmaceuticals Holding Corp
TNXP
$6.04-5.92%
End of day · as of Oct 16, 2026, 8:00 PM ET
Mkt cap
$194.48M
EV/Sales
-1.00
P/E ratio
N/A
FY2025 Revenue
$13.11M
EPS (TTM)
$-13.09
Gross Margin (FY2025)
49.34%
Profit Margin (FY2025)
-946.22%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Latest reported TNXP revenue for 2025-12-31 was $13.1M. Net income was -$124.0M. Revenue was up 29.8% from 2024-12-31 to 2025-12-31. TNXP currently screens at market cap $194.5M.
Use this TNXP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TNXP income, balance, and cash tables.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company in the Healthcare sector.
Latest cached Tonix Pharmaceuticals Holding Corp (TNXP) revenue for Dec 31, 2025 was $13.1M. Net income was -$124.0M. Statements: https://lician.com/financials/tnxp
Tonix Pharmaceuticals Holding Corp (TNXP) market capitalization is $194.5M on the latest cached snapshot.
Tonix Pharmaceuticals Holding Corp (TNXP) cached previous close $6.42; day range $6.04 – $6.46; volume 929,447. Session quote: https://lician.com/quote/tnxp
Tonix Pharmaceuticals Holding Corp (TNXP) latest cached earnings event is "TNXP earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TNXP filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/tnxp